Or does the age of the patient change what you might do? So

with at least the atopic drugs, and specifically in the IL-4s and 13s, we probably don't have to be doing any of this.

Where that changes, though, is when you're getting into JAK inhibitors.

Certainly, I think that mechanistically, based on the level of immunosuppression that those medicines can cause, checking a routine baseline quantifier on test, as well as a hepatitis panel, if your patient hasn't been tested before, is certainly reasonable.

There are beyond those testing for infections, whether or not we're checking liver function, CBC, lipids.

Certainly the label does say to check those.

We should be checking lipids.

So he calls up his buddy, Dr. Ellman.